970*90
768
468
mobile

Sun Pharma decreases after increasing stake in Ranbaxy Malaysia

Franchise India Bureau
Franchise India Bureau Oct 14 2017 - 1 min read
Sun Pharma decreases after increasing stake in Ranbaxy Malaysia
Sun Pharma reported total revenue at 1,802.52 crore and net loss stood at 1,290.99 crore

Shares of Sun Pharma ended lower on Friday after the drug company said it will increase its stake subsidiary Ranbaxy Malaysia to 79.5% through purchase of shares. Following the company statement the stock fell 0.87% to Rs 534.70 on BSE. It opened at Rs 541 and touched an intraday high and low of Rs 543 and 532.80.

In a filing to BSE, the company said "One of the wholly owned subsidiaries of the company has agreed to increase its stake holding in Ranbaxy Malaysia, by the way of purchase of 6,66,985 shares of face value of MYR 1 each. The total stake holding of Sun Pharma along with its wholly owned subsidiary will increase from 71.2 per cent to 79.5 per cent.”

For the quarter ended June 30, 2017, Sun Pharma reported total revenue at 1,802.52 crore and net loss stood at 1,290.99 crore.

Subscribe Newsletter
Submit your email address to receive the latest updates on news & host of opportunities
Entrepreneur Magazine

For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you

or Click here to Subscribe Online